Inspection Record

MedPark Pharmacy LLC — FDA 483 Findings

US FDAInspected 2018-05-22Published 2024-01-17 4 findingsAseptic processing and sterility assurance

Inspectors Stacie Woods · Djamila HarouakaThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

There is a lack of assurance of the sterility of prepared sterile human drugs and sterile veterinary drugs includin g injectable and opthalmic drug products.

2Aseptic processing and sterility assurance

The system for maintaining environmental conditions in the aseptic processing areas was deficient.

3Aseptic processing and sterility assurance

The aseptic technique used to prevent microbiological contamination of drug products purporting to be sterile was d eficient.

4Aseptic processing and sterility assurance

The system for cleaning and disinfection of the critical areas used to prepare sterile drug products is deficient.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

MedPark Pharmacy LLC company profile — full history US FDA documents, 2024 Go to Findings search